Integrated Diagnostics (UK) Insiders
IDHC Stock | 0.44 0.01 2.22% |
Integrated Diagnostics employs about 6.7 K people. The company is managed by 12 executives with a total tenure of roughly 15615 years, averaging almost 1301.0 years of service per executive, having 557.67 employees per reported executive. Breaking down Integrated Diagnostics' management performance can provide insight into the firm performance.
Sherif Zeiny Director Group Director |
Amid Abdelnour Executive Managing Biolab |
Integrated |
Integrated Diagnostics Management Team Effectiveness
The company has return on total asset (ROA) of 0.0969 % which means that it generated a profit of $0.0969 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2303 %, meaning that it generated $0.2303 on every $100 dollars invested by stockholders. Integrated Diagnostics' management efficiency ratios could be used to measure how well Integrated Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Integrated Diagnostics' Other Current Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 9.6 M in 2024, whereas Total Assets are likely to drop slightly above 4.1 B in 2024.Integrated Diagnostics Quarterly Income Before Tax |
|
Integrated Diagnostics Workforce Comparison
Integrated Diagnostics Holdings is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 235,155. Integrated Diagnostics holds roughly 6,692 in number of employees claiming about 2.85% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.17 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Integrated Diagnostics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Integrated Diagnostics Price Series Summation is a cross summation of Integrated Diagnostics price series and its benchmark/peer.
Integrated Diagnostics Notable Stakeholders
An Integrated Diagnostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Integrated Diagnostics often face trade-offs trying to please all of them. Integrated Diagnostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Integrated Diagnostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sherif Zeiny | Group Director | Profile | |
Tarek Yehia | Director Relations | Profile | |
Nancy Fahmy | Investor Director | Profile | |
Seham Ibrahim | Sales Director | Profile | |
Hend Sherbini | Group Director | Profile | |
Amid Abdelnour | Managing Biolab | Profile | |
Eissa Khorshid | Chief Officer | Profile | |
Osama Zaghloul | Managing Ultralab | Profile | |
Omar Bedewy | Group Strategies | Profile | |
Moushira Saifi | Head Department | Profile | |
Mohamed Saleh | General Counsel | Profile | |
Mohamed Nouh | Head Administrator | Profile |
About Integrated Diagnostics Management Performance
The success or failure of an entity such as Integrated Diagnostics often depends on how effective the management is. Integrated Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Integrated management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Integrated management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Integrated Diagnostics is entity of United Kingdom. It is traded as Stock on LSE exchange.
Please note, the imprecision that can be found in Integrated Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Integrated Diagnostics Holdings. Check Integrated Diagnostics' Beneish M Score to see the likelihood of Integrated Diagnostics' management manipulating its earnings.
Integrated Diagnostics Workforce Analysis
Traditionally, organizations such as Integrated Diagnostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Integrated Diagnostics within its industry.Integrated Diagnostics Manpower Efficiency
Return on Integrated Diagnostics Manpower
Revenue Per Employee | 616K | |
Revenue Per Executive | 343.5M | |
Net Income Per Employee | 110.2K | |
Net Income Per Executive | 61.4M | |
Working Capital Per Employee | 102.7K | |
Working Capital Per Executive | 57.2M |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.